Elacentra
Elacentra is Elacestrant, an oral selective estrogen receptor degrader (SERD). It is indicated for ER-positive, HER2-negative advanced or metastatic breast cancer, particularly after endocrine resistance and works by degrading the estrogen receptor and suppressing estrogen-driven tumor signaling.
Features
| Product Name | Elacentra |
| Generic Name | Elacestrant |
| Formulation | Tablet |
| Available Pack Size | 4X7's |
| Available Strength | 345MG |